E

DarioHealth Corp. DRIO

NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

DarioHealth Corp. is a digital health company focused on chronic condition management through connected software, data analytics, behavioral coaching, and remote monitoring solutions. The company operates primarily in the digital therapeutics and virtual care industries, with offerings targeting diabetes, hypertension, weight management, musculoskeletal conditions, and behavioral health. DarioHealth generates revenue primarily through business-to-business-to-consumer arrangements with employers, health plans, healthcare providers, and strategic partners, alongside limited direct-to-consumer sales of connected devices and subscription services.

The company’s core platform combines mobile applications, connected medical devices, coaching services, and artificial intelligence-driven engagement tools intended to improve patient outcomes and reduce healthcare costs. DarioHealth evolved from an earlier focus on glucose monitoring technology after merging with LabStyle Innovations Corp. and subsequently expanded into broader chronic care management through acquisitions and platform integration. Its strategic positioning centers on delivering an integrated multi-condition digital health platform designed to address comorbid chronic conditions within a single user experience.

Business Operations

DarioHealth operates through integrated digital health offerings rather than large separately reported industrial divisions. Its primary operational focus includes chronic condition management programs for diabetes, hypertension, weight management, musculoskeletal care, and behavioral health. Revenue is generated through recurring software subscriptions, employer and health-plan contracts, performance-based healthcare arrangements, and sales of connected monitoring devices. The company’s platform integrates proprietary mobile software, cloud-based analytics, coaching infrastructure, and connected devices such as blood glucose monitors and blood pressure monitoring tools.

The company has expanded its capabilities through acquisitions and partnerships, including the acquisition of wayForward, a behavioral health platform, and Physimax Technologies Ltd., which strengthened its musculoskeletal and motion-analysis capabilities. DarioHealth also acquired assets associated with Twill’s care technology operations to broaden its engagement and digital care management capabilities. Operations are concentrated in the United States, which represents the company’s primary commercial market, while development and technology functions also maintain ties to Israel. Strategic collaborations with employers, health plans, and healthcare ecosystem participants are central to customer acquisition and deployment.

Strategic Position & Investments

DarioHealth’s strategic direction emphasizes becoming a unified digital chronic care platform capable of addressing multiple interconnected health conditions through one engagement system. The company has prioritized enterprise healthcare contracting, expansion of recurring revenue arrangements, and increased adoption among self-insured employers and health plans. Growth initiatives have focused on cross-selling multiple condition-management programs to existing customers and leveraging data analytics to improve clinical engagement and outcomes.

Acquisitions have played a central role in expanding the company’s capabilities. The acquisitions of Physimax Technologies Ltd. and wayForward broadened DarioHealth’s reach into musculoskeletal and behavioral health management, while additional technology and platform acquisitions enhanced member engagement and care coordination. The company continues to invest in artificial intelligence-enabled personalization, digital coaching infrastructure, and remote patient monitoring technologies intended to support value-based healthcare delivery. Its strategic positioning reflects broader healthcare trends toward virtual care, preventative chronic disease management, and integrated digital health ecosystems.

Geographic Footprint

DarioHealth is headquartered in New York, United States, with operational and development activities also connected to Israel. The company’s commercial focus is concentrated in the United States, where it serves employers, health plans, healthcare organizations, and consumers seeking digital chronic care solutions. The U.S. market represents the substantial majority of the company’s revenue and strategic growth activity.

The company maintains an international operational footprint through technology development, research activities, and historical corporate ties in Israel, while its digital platform architecture allows services to be deployed remotely across multiple regions. Although DarioHealth has broader international accessibility through app-based services and digital distribution, publicly available disclosures indicate that its primary market influence and commercial operations remain centered in North America.

Leadership & Governance

DarioHealth was formed through the evolution of LabStyle Innovations and subsequent strategic expansion into digital chronic care management. Leadership has emphasized building an integrated, data-driven digital therapeutics platform capable of addressing multiple chronic conditions within a unified patient engagement environment. The company’s governance and strategic direction have consistently focused on healthcare cost reduction, member engagement, and scalable virtual care delivery.

Key executives include:

  • Erez Raphael – Chief Executive Officer
  • Steven Nelson – Chief Commercial Officer
  • Ricky Goldwasser – Chief Financial Officer
  • Yifat Hershcovitz – Chief Technology Officer
  • Oren Nissim – President
  • Zvi Aharoni – Chairman of the Board

The company’s leadership strategy emphasizes integrated chronic care delivery, enterprise healthcare partnerships, and technology-enabled patient engagement. Public filings and investor communications indicate a continued focus on scaling recurring revenue models, expanding payer and employer relationships, and improving clinical outcomes through connected digital care solutions.

Data compiled by narrative technology. May contain errors.

Top Tech Stocks
See All »
B
NVDA NASDAQ $228.87
B
AAPL NASDAQ $339.75
B
AVGO NASDAQ $364.54
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $110.12
A
Top Financial Stocks
See All »
B
B
JPM NYSE $340.00
B
V NYSE $362.04
Top Health Care Stocks
See All »
B
LLY NYSE $1,170.14
B
JNJ NYSE $269.19
B
ABBV NYSE $265.21
Top Real Estate Stocks
See All »
B
PLD NYSE $135.88
B
EQIX NASDAQ $1,059.26